Leasing or Buying the Equipment Is a Liquidity Decision. In 2026 the Wrong Default Costs More Than the Rate.

A reimbursement change that took effect in January quietly turned every equipment financing choice into a cash-position decision, and most practices are still treating it as a procurement one.

The 2026 Medicare Physician Fee Schedule cut payment for facility-based physician services by roughly 7% as of January 1, while paying about 4% more for the same services delivered in a non-facility office setting. For a practice carrying imaging, surgical, or lab equipment, that swing lands at the exact moment capital is needed to invest, and it changes which equipment financing structure a practice can actually afford to carry.

The margin math moved before most practices repriced their capital plan

The site-of-service split is not a rounding error. The American Medical Association estimates that more than a third of oncologists face cuts between 10% and 20% next year once the facility adjustment and the efficiency adjustment compound. At the same time, the cost of running a practice keeps climbing: CMS itself projects practice costs will grow 2.7% in 2026 as measured by the Medicare Economic Index. Revenue down where care is delivered in facilities, costs up across the board, and a 2.5% statutory payment increase that an offsetting 2.5% efficiency adjustment largely erases.

That is the squeeze. The instinct under a squeeze is to cut, but the practices that hold position are the ones moving volume toward the better-paid non-facility setting, which usually means investing in equipment and space rather than retreating from it. The capital to do that has to come from somewhere, and where it comes from is now a margin decision.

Short technology cycles make the structure matter more than the rate

Diagnostic imaging, lab systems, surgical tools, and the platforms behind them carry technology cycles short enough that a cash purchase can strand six figures in equipment that is functionally obsolete before it is fully depreciated. Leasing is often the right answer precisely because it preserves liquidity while keeping access to current technology, as a recent Medical Economics analysis on practice financing laid out in June. Term debt is the better answer when the asset holds its value over a longer horizon. Sale-leaseback is the answer when capital is already trapped in owned equipment or real estate and needs to be redeployed into clinical expansion or staffing.

None of those is universally correct. The error is not picking the wrong one in the abstract. The error is letting the first lender a practice calls decide the structure by default, because that lender offers one product. A five to ten year term loan with a personal guarantee, which the same analysis notes is still common for smaller and independent practices, is a fine instrument for the right asset and an expensive way to finance something that will be replaced in three years.

What lenders actually underwrite, and why partial answers cost the most

Equipment underwriting in healthcare turns on debt service coverage, historical and projected cash flow, payer mix stability, and operator track record. A practice with strong commercial payer exposure and clean revenue cycle management underwrites well and tends to get more structure options. A practice that walks into a single lender without packaging that story tends to get one offer, often the lender's standard product, and concludes that product is the market. It is not. It is one data point.

The cost of the wrong structure is rarely the interest rate spread. It is the liquidity locked away: cash committed to a long amortization on a short-lived asset, or trapped in owned equipment that a sale-leaseback could have freed at the moment the practice needed working capital to add a non-facility service line. The cost of the wrong structure is rarely the interest rate spread. It is the liquidity locked away: cash committed to a long amortization on a short-lived asset, or trapped in owned equipment that a sale-leaseback could have freed at the moment the practice needed working capital to add a non-facility service line. The decline is not abstract. The share of physicians in wholly physician-owned private practices fell from 60.1% in 2012 to 46.7% in 2022 and 42.2% in 2024, per the AMA Physician Practice Benchmark Survey, an 18-point drop, and the AMA attributes it to inadequate payment, rising practice costs, and administrative burden. Mis-structured equipment debt is one more reason owners run out of room and sell.

How Thalos Capital Approaches This

Thalos Capital treats an equipment decision as a capital structure question, not a product selection. The Equipment Financing approach starts from the asset: its useful life, its upgrade cycle, and how it earns. Fast-cycling technology is matched to leasing so liquidity stays available. Durable assets are matched to term structures. Capital already trapped in owned equipment or facilities is evaluated for sale-leaseback so it can be redeployed where it produces return.

The mechanism that makes this work is reach and packaging. Rather than accept one lender's single product, Thalos Capital positions the deal, models the liquidity impact of each structure, and brings options from a vetted capital network, then runs the process to close. The Capital Structure Advisory work sequences these facilities so an equipment purchase today does not foreclose the working capital a practice needs six months from now. The point is not a cheaper rate. It is keeping the practice's cash where it can defend margin.

The 2026 reimbursement environment did not make equipment cheaper or financing simpler. It raised the cost of choosing a structure by default. A practice that finances a three-year asset on a ten-year guarantee, or buys outright what it should have leased, will feel that decision long after the rate stops mattering.

Most financing situations have more options than the borrower initially sees. A conversation is enough to map them. Submit your financing request at https://thaloscapital.com/contact